Investigation of BRAF mutation in a series of papillary thyroid carcinoma and matched-lymph node metastasis with ARMS PCR-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Investigation of BRAF mutation in a series of papillary thyroid carcinoma and matched-lymph node metastasis with ARMS PCR

Published:2019-04 Issue:4 Volume:215 Page:761-765
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Zhang Jian,Yang Yaoyao,Zhao Jing,Shi Lifang,Xu Yanhua,Yu Kaikai,Guo Chongyong

Funder

Shang Dong Province Medicine and Health Development Foundation

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference32 articles.

1. Lymph node dissection in papillary thyroid carcinoma;Moo;Semin. Nucl. Med.,2011

2. Cancer statistics;Jemal;CA Cancer J. Clin.,2009

3. Cancer statistics;Jemal;CA Cancer J. Clin.,2010

4. Novel molecular targeted therapies for refractory thyroid cancer;Perez;Head Neck,2012

5. BRAF mutations in papillary thyroid carcinoma and emerging targeted therapies (review);Leonardi;Mol. Med. Rep.,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Association of Pretreatment Systemic Immune Inflammatory Response Index (SII) and Neutrophil-to-Lymphocyte Ratio (NLR) with Lymph Node Metastasis in Patients with Papillary Thyroid Carcinoma;International Journal of General Medicine;2024-07

2. Thyroglobulin Antibody (TgAb) Positive is an Independent Risk Factor for Lymph Node Metastasis in Patients with Differentiated Thyroid Carcinoma;International Journal of General Medicine;2023-12

3. Younger Than 55 Years Old and BRAF V600E Mutation are Risk Factors for Lymph Node Metastasis in Papillary Thyroid Carcinomas ≤1.0 cm but Not in >1.0 cm;International Journal of General Medicine;2023-04

4. Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern;Microbiology Spectrum;2022-02-23

5. Research Progress of BRAF V600E Gene Mutation in Papillary Thyroid Carcinoma;Advances in Clinical Medicine;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3